[第三代头孢菌素治疗社区获得性肺炎的临床和药物经济学效果评价]。

Problemy tuberkuleza i boleznei legkikh Pub Date : 2009-01-01

O I Starodubtseva, Ia M Vakhrushev

{"title":"[第三代头孢菌素治疗社区获得性肺炎的临床和药物经济学效果评价]。","authors":"O I Starodubtseva, Ia M Vakhrushev","doi":"","DOIUrl":null,"url":null,"abstract":"The clinical and pharmacoeconomic effectiveness of the third-generation cephalosporin Ceftriabol versus the original drug Claforan in the treatment of varying community-acquired pneumonia was studied in 60 and 58 patients, respectively. The Russian third-generation cephalosporin Ceftriabol was shown to be as effective as Claforan in treating patients with community-acquired pneumonia. However, in addition to the main--therapeutic effect, Ceftriabol produces a certain economic gain.","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 6","pages":"28-9"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].\",\"authors\":\"O I Starodubtseva, Ia M Vakhrushev\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The clinical and pharmacoeconomic effectiveness of the third-generation cephalosporin Ceftriabol versus the original drug Claforan in the treatment of varying community-acquired pneumonia was studied in 60 and 58 patients, respectively. The Russian third-generation cephalosporin Ceftriabol was shown to be as effective as Claforan in treating patients with community-acquired pneumonia. However, in addition to the main--therapeutic effect, Ceftriabol produces a certain economic gain.\",\"PeriodicalId\":85348,\"journal\":{\"name\":\"Problemy tuberkuleza i boleznei legkikh\",\"volume\":\" 6\",\"pages\":\"28-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Problemy tuberkuleza i boleznei legkikh\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy tuberkuleza i boleznei legkikh","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

分别在60例和58例患者中研究了第三代头孢菌素Ceftriabol与原药clforan治疗不同社区获得性肺炎的临床和药物经济学效果。俄罗斯第三代头孢菌素Ceftriabol被证明在治疗社区获得性肺炎患者方面与clforan一样有效。然而，除了主要的治疗效果外，头孢曲博还产生了一定的经济效益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].

The clinical and pharmacoeconomic effectiveness of the third-generation cephalosporin Ceftriabol versus the original drug Claforan in the treatment of varying community-acquired pneumonia was studied in 60 and 58 patients, respectively. The Russian third-generation cephalosporin Ceftriabol was shown to be as effective as Claforan in treating patients with community-acquired pneumonia. However, in addition to the main--therapeutic effect, Ceftriabol produces a certain economic gain.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Problemy tuberkuleza i boleznei legkikh

自引率

0.00%

发文量